首页> 外文期刊>British Journal of Cancer >Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma
【24h】

Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma

机译:肾素和血管紧张素原的表达及其在人胶质母细胞瘤生长和凋亡中的作用

获取原文
获取外文期刊封面目录资料

摘要

The expression and function in growth and apoptosis of the renin–angiotensin system (RAS) was evaluated in human glioblastoma. Renin and angiotensinogen (AGT) mRNAs and proteins were found by in situ hybridisation and immunohistochemistry in glioblastoma cells. Angiotensinogen was present in glioblastoma cystic fluids. Thus, human glioblastoma cells produce renin and AGT and secrete AGT. Human glioblastoma and glioblastoma cells expressed renin, AGT, renin receptor, AT2 and/or AT1 mRNAs and proteins determined by RT–PCR and/or Western blotting, respectively. The function of the RAS in glioblastoma was studied using human glioblastoma cells in culture. Angiotensinogen, des(Ang I)AGT, tetradecapaptide renin substrate (AGT1–14), Ang I, Ang II or Ang III, added to glioblastoma cells in culture, did not modulate their proliferation, survival or death. Angiotensin-converting enzyme inhibitors did not diminish glioblastoma cell proliferation. However, the addition of selective synthetic renin inhibitors to glioblastoma cells decreased DNA synthesis and viable tumour cell number, and induced apoptosis. This effect was not counterbalanced by concomitant addition of Ang II. In conclusion, the complete RAS is expressed by human glioblastomas and glioblastoma cells in culture. Inhibition of renin in glioblastoma cells may be a potential approach to control glioblastoma cell proliferation and survival, and glioblastoma progression in combination therapy.
机译:在人胶质母细胞瘤中评估了肾素-血管紧张素系统(RAS)在生长和凋亡中的表达和功能。通过胶质母细胞瘤细胞的原位杂交和免疫组织化学发现了肾素和血管紧张素原(AGT)mRNA和蛋白。血管紧张素原存在于成胶质细胞瘤囊性液体中。因此,人胶质母细胞瘤细胞产生肾素和AGT并分泌AGT。人胶质母细胞瘤和胶质母细胞瘤细胞分别通过RT-PCR和/或Western blotting检测肾素,AGT,肾素受体,AT2和/或AT1 mRNA和蛋白。使用培养的人胶质母细胞瘤细胞研究了RAS在胶质母细胞瘤中的功能。血管紧张素原,des(Ang I)AGT,四癸素肾素底物(AGT1-14),Ang I,Ang II或Ang III添加到培养的胶质母细胞瘤细胞中,并不能调节其增殖,存活或死亡。血管紧张素转换酶抑制剂不会减少胶质母细胞瘤细胞增殖。但是,向胶质母细胞瘤细胞中添加选择性合成肾素抑制剂会降低DNA合成和存活的肿瘤细胞数量,并诱导凋亡。伴随加入Ang II不能抵消这种作用。总之,完整的RAS由培养的人胶质母细胞瘤和胶质母细胞瘤细胞表达。在胶质母细胞瘤细胞中抑制肾素可能是在联合治疗中控制胶质母细胞瘤细胞增殖和存活以及胶质母细胞瘤进展的潜在方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号